ENHANCED SELECTIVITY OF PARGYLINE AS AN INHIBITOR OF TYPE-B MONO-AMINE OXIDASE IN HARMALINE-TREATED RATS

被引:20
作者
FULLER, RW
HEMRICK, SK
机构
关键词
D O I
10.1016/0024-3205(78)90278-3
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
引用
收藏
页码:1083 / 1086
页数:4
相关论文
共 8 条
[1]  
FULLER RW, 1968, ARCH INT PHARMACOD T, V174, P32
[2]  
FULLER RW, 1972, ARCH INT PHARMACOD T, V198, P270
[3]   THE INTERACTION BETWEEN REVERSIBLE AND IRREVERSIBLE MONOAMINE OXIDASE INHIBITORS [J].
HORITA, A ;
MCGRATH, WR .
BIOCHEMICAL PHARMACOLOGY, 1960, 3 (03) :206-211
[4]  
LOWE MC, 1975, J PHARMACOL EXP THER, V194, P522
[5]   EVIDENCE FOR A CLORGYLINE-RESISTANT MONOAMINE METABOLIZING ACTIVITY IN RAT-HEART [J].
LYLES, GA ;
CALLINGHAM, BA .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1975, 27 (09) :682-691
[6]  
PLANZ G, 1973, ARZNEIMITTEL-FORSCH, V23, P281
[7]   ANTAGONISM BETWEEN HARMALINE AND LONG-ACTING MONOAMINE OXIDASE INHIBITORS CONCERNING THE EFFECT ON 5-HYDROXYTRYPTAMINE AND NOREPINEPHRINE METABOLISM IN THE BRAIN [J].
PLETSCHER, A ;
BESENDORF, H .
EXPERIENTIA, 1959, 15 (01) :25-26
[8]  
SPECTOR S, 1960, J PHARMACOL EXP THER, V130, P256